Medtronic
MDT
2,024 hedge funds and large institutions have $180B invested in Medtronic in 2021 Q3 according to their latest regulatory filings, with 125 funds opening new positions, 937 increasing their positions, 675 reducing their positions, and 79 closing their positions.
58% more first-time investments, than exits
New positions opened: 125 | Existing positions closed: 79
39% more repeat investments, than reductions
Existing positions increased: 937 | Existing positions reduced: 675
8% more call options, than puts
Call options by funds: $1.09B | Put options by funds: $1.01B
1% more funds holding
Funds holding: 2,004 → 2,024 (+20)
1% more capital invested
Capital invested by funds: $179B → $180B (+$988M)
0.7% less ownership
Funds ownership: 80.98% → 80.28% (-0.7%)
2% less funds holding in top 10
Funds holding in top 10: 56 → 55 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$250M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$245M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$154M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$130M |
| 5 |
Goldman Sachs
New York
|
+$126M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$265M |
| 2 |
D.E. Shaw & Co
New York
|
-$248M |
| 3 |
KBC Group
Brussels,
Belgium
|
-$213M |
| 4 |
BlackRock
New York
|
-$207M |
| 5 |
Millennium Management
New York
|
-$179M |
MDT Hedge Fund Activity: Q3 2021 in Review
2,024 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q3 2021, worth a combined $180B — up 0.55% from $179B a quarter earlier.
Buyers outnumbered sellers: 125 funds opened new MDT positions and 79 closed out — a net gain of 46 holders — while 937 added to existing stakes and 675 trimmed.
The largest buyer was Sustainable Growth Advisers, adding an estimated $250M. The largest seller was JP Morgan Chase, cutting an estimated $265M.
- 2,024 institutional investors held Medtronic (MDT) as of Q3 2021, up from 2,004 in Q2 2021.
- Funds reported $180B of Medtronic stock for Q3 2021, up 0.55% quarter-over-quarter.
- 125 funds opened new Medtronic positions in Q3 2021 and 79 closed out, a net change of +46 holders.
- The largest Medtronic buyer in Q3 2021 was Sustainable Growth Advisers, an estimated $250M added.
- The largest Medtronic seller in Q3 2021 was JP Morgan Chase, an estimated $265M sold.
Based on aggregated 13F filings for Q3 2021.